Bacteria show remarkable adaptability in the face of antibiotic therapeutics. Resistance alleles in drug target-specific sites and general stress responses have been identified in individual endpoint isolates 1-7. Less is known, however, about the population dynamics during the development of antibiotic-resistant strains. Here we follow a continuous culture of Escherichia coli facing increasing levels of antibiotic and show that the vast majority of isolates are less resistant than the population as a whole. We find that the few highly resistant mutants improve the survival of the population's less resistant constituents, in part by producing indole, a signalling molecule generated by actively growing, unstressed cells8. We show, through transcriptional profiling, that indole serves to turn on drug efflux pumps and oxidative-stress protective mechanisms. The indole production comes at a fitness cost to the highly resistant isolates, and whole-genome sequencing reveals that this bacterial altruism is made possible by drugresistance mutations unrelated to indole production. This work establishes a population-based resistance mechanism constituting a form of kin selection 9 whereby a small number of resistant mutants can, at some cost to themselves, provide protection to other, more vulnerable, cells, enhancing the survival capacity of the overall population in stressful environments. © 2010 Macmillan Publishers Limited. All rights reserved.
CITATION STYLE
Lee, H. H., Molla, M. N., Cantor, C. R., & Collins, J. J. (2010). Bacterial charity work leads to population-wide resistance. Nature, 467(7311), 82–85. https://doi.org/10.1038/nature09354
Mendeley helps you to discover research relevant for your work.